- In May 2024, Integer Holdings Corporation, a leading U.S.-based contract medical device manufacturer, announced the expansion of its facility in Alden, New York. This initiative aims to increase production capacity and improve cleanroom manufacturing capabilities for cardiovascular and neuromodulation devices. The expansion reflects Integer’s commitment to supporting OEMs with advanced manufacturing solutions and meeting the rising demand for outsourced production of high-complexity Class III medical devices in North America
- In April 2024, Viant Medical, a prominent medical device outsourcing partner, acquired LayerMed, a Canada-based design and development firm specializing in minimally invasive surgical instruments. The acquisition enhances Viant’s front-end innovation capabilities and accelerates its ability to offer end-to-end development services to OEMs. This strategic move strengthens Viant’s position in the North American outsourcing ecosystem by broadening its service offerings and geographic reach
- In March 2024, Sanmina Corporation, a U.S.-based contract manufacturer, launched a new digital platform designed to streamline medical device prototyping and reduce design-to-manufacture timelines. The platform incorporates AI-driven modeling and real-time regulatory tracking, enabling faster design iterations and improved compliance. This development underscores Sanmina’s focus on integrating digital transformation into medical device outsourcing services
- In February 2024, TE Connectivity opened a new innovation and manufacturing center in Hermosillo, Mexico, to expand its support for medical device OEMs across North America. The facility includes advanced molding, extrusion, and assembly capabilities for minimally invasive, interventional, and diagnostic devices. This expansion highlights the increasing demand for nearshore manufacturing solutions and TE’s commitment to offering vertically integrated services in a cost-effective location
- In January 2024, Jabil Healthcare, a division of Jabil Inc., announced a collaboration with a U.S.-based startup to develop AI-powered wearable medical devices targeting chronic disease management. Under the agreement, Jabil will provide end-to-end outsourcing services including design, miniaturization, and regulatory support. This partnership demonstrates the growing role of contract manufacturers in accelerating innovation and commercialization for next-generation medical technologies in the North American market
